chr12-101877899-A-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_018370.3(DRAM1):c.110A>T(p.Asn37Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000481 in 1,539,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000050 ( 0 hom. )
Consequence
DRAM1
NM_018370.3 missense
NM_018370.3 missense
Scores
6
13
Clinical Significance
Conservation
PhyloP100: 3.58
Genes affected
DRAM1 (HGNC:25645): (DNA damage regulated autophagy modulator 1) This gene is regulated as part of the p53 tumor suppressor pathway. The gene encodes a lysosomal membrane protein that is required for the induction of autophagy by the pathway. Decreased transcriptional expression of this gene is associated with various tumors. This gene has a pseudogene on chromosome 4. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3503551).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DRAM1 | NM_018370.3 | c.110A>T | p.Asn37Ile | missense_variant | 1/7 | ENST00000258534.13 | NP_060840.2 | |
DRAM1 | XM_005269004.3 | c.110A>T | p.Asn37Ile | missense_variant | 1/6 | XP_005269061.1 | ||
DRAM1 | XM_005269005.3 | c.110A>T | p.Asn37Ile | missense_variant | 1/5 | XP_005269062.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DRAM1 | ENST00000258534.13 | c.110A>T | p.Asn37Ile | missense_variant | 1/7 | 1 | NM_018370.3 | ENSP00000258534.8 | ||
DRAM1 | ENST00000549365.1 | n.101A>T | non_coding_transcript_exon_variant | 1/5 | 3 | ENSP00000447171.1 | ||||
DRAM1 | ENST00000544152.5 | c.110A>T | p.Asn37Ile | missense_variant | 1/4 | 2 | ENSP00000445827.1 | |||
DRAM1 | ENST00000551403.1 | n.110A>T | non_coding_transcript_exon_variant | 1/6 | 5 | ENSP00000448075.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152004Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
152004
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000332 AC: 5AN: 150764Hom.: 0 AF XY: 0.0000497 AC XY: 4AN XY: 80546
GnomAD3 exomes
AF:
AC:
5
AN:
150764
Hom.:
AF XY:
AC XY:
4
AN XY:
80546
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000505 AC: 70AN: 1387040Hom.: 0 Cov.: 31 AF XY: 0.0000438 AC XY: 30AN XY: 684716
GnomAD4 exome
AF:
AC:
70
AN:
1387040
Hom.:
Cov.:
31
AF XY:
AC XY:
30
AN XY:
684716
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152004Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74240
GnomAD4 genome
AF:
AC:
4
AN:
152004
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74240
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 01, 2022 | The c.110A>T (p.N37I) alteration is located in exon 1 (coding exon 1) of the DRAM1 gene. This alteration results from a A to T substitution at nucleotide position 110, causing the asparagine (N) at amino acid position 37 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;D
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
P;.
Vest4
MutPred
Loss of sheet (P = 0.0817);Loss of sheet (P = 0.0817);
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at